Company name
2022Founder
Kayhan Moayeri leads Pure Monograph, which builds pharmaceutical intelligence tools that assemble cited evidence about drug programs and analyze clinical trials, marking gaps in the source material. He founded the company after working in pharmaceutical development and manufacturing, and his writing examines how AI can be evaluated for accuracy in scientific and regulatory contexts.